Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
CC transcript
|
|
UNITED THERAPEUTICS Corp (UTHR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 1,259 shares
@ $232.9592, valued at
$293.3k
Sold 2,141 shares
@ $233.529, valued at
$500k
Sold 600 shares
@ $236.8764, valued at
$142.1k
Sold 300 shares
@ $238.3933, valued at
$71.5k
Sold 400 shares
@ $239.9875, valued at
$96k
Sold 1,000 shares
@ $241.611, valued at
$241.6k
Sold 300 shares
@ $243.13, valued at
$72.9k
Exercised 6,000 options
@ $117.76, valued at
$706.6k
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
4
| SULLIVAN LOUIS W (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 3,913 shares
@ $214.5786, valued at
$839.6k
Sold 1,187 shares
@ $215.5178, valued at
$255.8k
Sold 700 shares
@ $217.2366, valued at
$152.1k
Sold 200 shares
@ $218.17, valued at
$43.6k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 07/07/2023 |
4
| Thompson Tommy G (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| Olian Judy D. (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 1,750 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| Mesa Nilda (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| KURZWEIL RAY (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| Klein Katherine J (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 880 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| DWEK RAYMOND (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 1,750 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| CAUSEY CHRISTOPHER (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 1,750 restricted stock units
@ $0 |
|
| 07/07/2023 |
4
| Giltner Richard (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Exercised 1,750 restricted stock units
@ $0 |
|
| 06/15/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 3,736 shares
@ $227.5162, valued at
$850k
Sold 2,264 shares
@ $228.1951, valued at
$516.6k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 06/01/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 400 shares
@ $207.01, valued at
$82.8k
Sold 2,750 shares
@ $208.7945, valued at
$574.2k
Sold 2,850 shares
@ $209.7153, valued at
$597.7k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 05/23/2023 |
4
| Giltner Richard (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Disposed/sold 5,000 shares
@ $218.59, valued at
$1.1M
Exercised 5,000 options to buy
@ $63.9, valued at
$319.5k
|
|
| 05/18/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 2,994 shares
@ $214.2674, valued at
$641.5k
Sold 3,006 shares
@ $214.889, valued at
$646k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 05/11/2023 |
4
| PATUSKY CHRISTOPHER (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Disposed/sold 2,000 shares
@ $212.24, valued at
$424.5k
Exercised 2,000 options to buy
@ $88.03, valued at
$176.1k
|
|
| 05/08/2023 |
4
| Mesa Nilda (Director) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 374 shares
@ $214.805, valued at
$80.3k
|
|
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|